GLPG0259 in Methotrexate-refractory Rheumatoid Arthritis
Clinical trial NCT01211249 · COMPLETED
Trial details
- NCT number
- NCT01211249
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.